GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Up 217.6% in February

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 104,500 shares, an increase of 217.6% from the January 31st total of 32,900 shares. Approximately 1.0% of the company’s stock are sold short. Based on an average daily volume of 3,380,000 shares, the short-interest ratio is currently 0.0 days.

GlucoTrack Price Performance

Shares of GlucoTrack stock traded up $0.01 during trading on Friday, hitting $0.36. 570,381 shares of the stock were exchanged, compared to its average volume of 5,653,275. The stock has a market cap of $3.76 million, a price-to-earnings ratio of -0.01 and a beta of -0.38. The firm’s 50-day moving average price is $2.25 and its 200 day moving average price is $22.29. GlucoTrack has a 12-month low of $0.33 and a 12-month high of $99.00.

Institutional Investors Weigh In On GlucoTrack

An institutional investor recently raised its position in GlucoTrack stock. Geode Capital Management LLC grew its holdings in GlucoTrack, Inc. (NASDAQ:GCTK) by 315.3% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 112,787 shares of the company’s stock after buying an additional 85,626 shares during the period. Geode Capital Management LLC owned 14.10% of GlucoTrack worth $42,000 at the end of the most recent reporting period. 10.92% of the stock is owned by hedge funds and other institutional investors.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.